Stay updated on SBRT and Virus Therapy Before Pembrolizumab in Cancer Clinical Trial
Sign up to get notified when there's something new on the SBRT and Virus Therapy Before Pembrolizumab in Cancer Clinical Trial page.

Latest updates to the SBRT and Virus Therapy Before Pembrolizumab in Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has been updated to include new information about a study on metastatic non-small cell lung cancer, including the addition of collaborators and a revision number, while significant details about the trial's methodology and eligibility criteria have been removed.SummaryDifference47%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check74 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.9%
- Check88 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.9%
Stay in the know with updates to SBRT and Virus Therapy Before Pembrolizumab in Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SBRT and Virus Therapy Before Pembrolizumab in Cancer Clinical Trial page.